Function of Peritoneal Exudate Cells after Abdominal Surgery

References

• Leibovich S J., Ross R. The role of macrophages in wound repair. A study with hydrocortisone and anti-macrophage serum. Am J Pathol. 1975; 78: 71–76
   PubMed Web of Science ®Google Scholar
• Dizerega G S., Rodgers K E. The Peritoneum. Springer, New York 1992
   Google Scholar
• Orita H, Nakamura R M., Dizerega G S. Kinetic analysis of postoperative peritoneal healing: incorporation of proline and glucosamine by exudative and tissue repair cells. Surg Forum. 1985; 36: 467–468
   Google Scholar
• Simpson D M., Ross R. The neutrophilic leukocyte in wound repair. A study with antineutrophil serum. J Clin Invest. 1972; 51: 2009–2011
   PubMed Web of Science ®Google Scholar
• Shimanuki T, Nakamura R M., Dizerega G S. A kinetic analysis of peritoneal fluid cytology and arachidonic acid metabolism after abrasion and reabrasion of rabbit peritoneum. J Surg Res. 1986; 41: 245–251
   PubMed Web of Science ®Google Scholar
• Orita H, Campeau J D., Gale J A., Nakamura R M., Dizerega G S. Differential secretion of plasminogen activator activity by postsurgical activated macrophages. J Surg Res. 1986; 41: 569–573
   PubMedGoogle Scholar
• Bryant S M., Hill H R. Enhanced chemiluminescence production by purified macrophage monolayers from C parvum-treated mice. Immunopharmacology. 1981; 3: 19–28
   Google Scholar
• Johnston R B., Jr., Pabst M J., Speer C HP, Hedegaard H B., Rest R F., Bryant S M. Enhancement of the oxidative metabolic response of macrophages by proteolytic enzymes. Mononuclear Phagocytes in Inflammation., R Van Furth. Martinus-Nijhoff, Boston 1985
   Google Scholar
• Bryant S M., Lynch R E., Hill H R. Kinetic analysis of superoxide anion production by activated and resident murine peritoneal macrophages. Cell Immunol. 1982; 96: 46–53
   Google Scholar
• Johnston R B., Jr., Godzik C A., Cohn Z A. Increased superoxide anion production by immunologically activated and chemically elicited macrophages. J Exp Med. 1978; 148: 115–119
   PubMed Web of Science ®Google Scholar
• Curnutte J T., Babior B M. Biological defense mechanisms: the effects of bacteria and serum on superoxide production by the granulocyte. J Clin Invest. 1974; 53: 1662–1666
   PubMed Web of Science ®Google Scholar
• Fukasawa M, Bryant S M., Dizerega G S. Superoxide anion production by postsurgical macrophages. J Surg Res. 1988; 45: 382–388
   PubMed Web of Science ®Google Scholar
• Kuraoka S, Campeau J D., Nakamura R M., Dizerega G S. Modulation of postsurgical macrophage function by early postsurgical polymorphonuclear leukocytes. J Surg Res., In press
   Google Scholar
• Vanderhock J Y., Bailey J M. Activation of a 15-lipoxygenase/leukotriene pathway in human polymorphonuclear leukocytes by the anti-inflammatory agent ibuprofen. J Biol Chem. 1984; 259: 6752–6755
   Google Scholar
• Rodgers K E., Ellefson D, Girgis W, Scott L, Dizerega G S. Effects of tolmetin sodium dihydrate on normal and postsurgical cell function. Int J Immunopharmacol. 1988; 10: 111–120
   PubMedGoogle Scholar
• Postlethwaite A E., Lachman L B., Mainadri C L., Kang A H. Interleukin-1 stimulation of collagenase production by cultured fibroblasts. J Exp Med. 1983; 157: 801–806
   PubMed Web of Science ®Google Scholar
• Bevilacqua M P., Schleef R R., Gimbrone M A., Loskutoff D J. Regulation of fibrinolytic system of cultured human vascular endothelium by interleukin 1. J Clin Invest. 1986; 78: 587–591
   PubMed Web of Science ®Google Scholar
• Abe H, Rodgers K E., Ellefson D, Dizerega G S. Kinetics of interleukin-1 secretion by murine macrophages recovered from the peritoneal cavity after surgery. J Surg Res. 1989; 47: 178–182
   PubMed Web of Science ®Google Scholar
• Gillis S, Mizel S B. T-Cell lymphoma model for the analysis of interleukin 1-mediated T-cell activation. Proc Natl Acad Sci USA. 1981; 78: 113–117
   Google Scholar
• Abe H, Rodgers K E., Ellefson D, Dizerega G S. Kinetics of interleukin-1 and tumor necrosis factor secretion by rabbit macrophages recovered from the peritoneal cavity after surgery. J Invest Surg. 1991; 4: 141–151
   PubMedGoogle Scholar
• Green L M., Reade J L., Ware C F. Rapid colortmetric method for cell viability: application to the quantitation of cytotoxic and growth inhibitory lymphokines. J Immunol Meth. 1984; 70: 257–268
   PubMed Web of Science ®Google Scholar
• Fukasawa M, Bryant S M., Dizerega G S. Incorporation of thymidine by fibroblasts: evidence for complex regulation by postsurgical macrophages. J Surg Res. 1988; 45: 460–466
   Google Scholar
• Fukasawa M, Bryant S M., Nakamura R M., Dizerega G S. Modulation of fibroblast proliferation by postsurgical macrophages. J Surg Res. 1987; 43: 513–520
   PubMed Web of Science ®Google Scholar
• Dower S K., Kronheim S R., March C J., et al. Detection and characterization of high affinity plasma membrane receptors for human interleukin 1. J Exp Med. 1985; 162: 501–515
   PubMed Web of Science ®Google Scholar
• Schmidt J A., Mizel S B., Cohen D, Green I. Interleukin 1, a potential regulator of fibroblast proliferation. J Immunol. 1982; 128: 2177–2182
   PubMed Web of Science ®Google Scholar
• Leibovich S J., Ross R. A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro. Am J Pathol. 1976; 84: 501–508
   PubMed Web of Science ®Google Scholar
• Bitterman P B., Wewers M D., Rennard S I., Adelberg S, Crystal R G. Modulation of alveolar macrophage-derived fibroblast proliferation by alternative macrophage mediators. J Clin Invest. 1986; 77: 700–713
   PubMed Web of Science ®Google Scholar
• Estes J E., Pledger W J., Gillespie G Y. Macrophage derived growth factor for fibroblasts and interleukin-1 are distinct entities. J Leukocyte Biol. 1984; 35: 115–128
   PubMed Web of Science ®Google Scholar
• Fukasawa M, Yanagihara D L., Rodgers K E., Dizerega G S. The mitogenic activity of peritoneal tissue repair cells: control by growth factors. J Surg Res. 1989; 47: 45–51
   Google Scholar
• Bronson R E., Bentiolami C N., Siebert E P. Modulation of fibroblast growth and glycosaminoglycan synthesis by interleukin-1. Collagen Relat Res. 1987; 7: 323–332
   PubMedGoogle Scholar
• Matsushima K, Bano M, Kidwell W R., Oppenheim J J. Interleukin-1 increases collagen type IV production by murine mammary epithelial cells. J Immunol. 1985; 134: 904–909
   PubMed Web of Science ®Google Scholar
• Zucali J R., Dinarello C A., Oblon D J., Gross M A., Anderson L, Weiner R S. Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2. J Clin Invest. 1986; 77: 1857–1863
   PubMed Web of Science ®Google Scholar
• Ko S D., Page R C., Narayanan A S. Fibroblast heterogeneity and prostaglandin regulation of subpopulation. Proc Natl Acad Sci USA. 1977; 74: 3429–3440
   PubMed Web of Science ®Google Scholar
• Schnyder J, Dewald B, Baggiolini M. Effects of cyclooxygenase inhibitors and prostaglandin E2 on macrophage activation in vitro. Prostaglandins. 1981; 22: 411–419
   PubMed Web of Science ®Google Scholar
• Phan S H., McGarry B M., Loeffler K M., Kunkel S L. Regulation of macrophage derived fibroblast growth factor release by arachidonate metabolites. J Leukocyte Biol. 1987; 42: 106–113
   PubMed Web of Science ®Google Scholar
• Korn J H., Halushka P V., LeRoy E C. Mononuclear cell modulation of connective tissue function: suppression of fibroblast growth by stimulation of endogenous prostaglandin production. J Clin Invest. 1980; 65: 543–554
   PubMed Web of Science ®Google Scholar
• Elias J A., Rossman M D., Zurier R B., Daniele R P. Human alveolar macrophage inhibition of lung fibroblast growth. A prostaglandin-dependent process. Am Rev Respir Dis. 1985; 131: 94–99
   PubMed Web of Science ®Google Scholar
• Unkeless J, Gordon S, Reich E. Secretion of plasminogen activator by stimulated macrophages. J Exp Med. 1974; 139: 834–850
   PubMed Web of Science ®Google Scholar
• Drapler J C., Pett J F. Involvement of prostaglandins in lipopolysaccharide-mediated regulation of plasminogen activator synthesis by inflammatory macrophages. Int J Immunopharmacol. 1984; 6: 345–352
   Google Scholar
• Wijnegaards G, Kluft C, Groenveld E. Demonstration of urokinase-related fibrinolytic activity in human serum. Br J Haematol. 1982; 51: 165–168
   Google Scholar
• Chapman H A., Stone O L. Characterization of a macrophage-derived plasminogen activator inhibitor. Similarities with placental urokinase inhibitor. Biochem J. 1985; 230: 109–114
   PubMedGoogle Scholar
• Saksela O, Hovi T, Vaheri A. Urokinase-type plasminogen activator and its inhibitor secreted by cultured human monocyte-macrophages. J Cell Physiol. 1985; 122: 125–131
   PubMed Web of Science ®Google Scholar
• Fukasawa M, Campeau J D., Girgis W, Bryant S M., Rodgers K E., Dizerega G S. Production of protease inhibitors by postsurgical macrophages. J Surg Res. 1989; 46: 256–261
   PubMed Web of Science ®Google Scholar
• Miller C L., Graziano C J., Lim R C. Human monocyte plasminogen activator production: correlation to altered M-T lymphocyte interaction. J Immunol. 1982; 128: 2194–2198
   Google Scholar
• Hovi T, Mosher D, Vaheri A. Cultured human monocytes synthesize and secrete α2-macroglobulin. J Exp Med. 1977; 145: 1580–1592
   PubMed Web of Science ®Google Scholar
• Wohlwend A, Belin D, Vassalli J D. Plasminogen activator-specific inhibitors in mouse macrophages: in vivo and in vitro modulation of their synthesis and secretion. J Immunol. 1987; 139: 1278–1284
   Google Scholar
• Chapman H A., Jr., Vavrin Z, Hibbs J B., Jr. Macrophage fibrinolytic activity: identification of two pathways of plasmin formation by intact cells and of a plasminogen activator inhibitor. Cell. 1982; 28: 653–659
   PubMedGoogle Scholar
• Chapman H A., Jr., Stone O L. Characterization of a macrophage-derived plasminogen-activator inhibitor. Similarities with placental urokinase inhibitor. Biochem J. 1985; 230: 109–114
   PubMedGoogle Scholar
• Paramo J A., deBoer A, Colucci M, Jonker J JC, Collen D. Plasminogen activator inhibitor (plasminogen activator-inhibitor) activity in the blood of patients with deep vein thrombosis. Thromb Haemostasis. 1985; 54: 725–729
   Google Scholar
• Samama M, Nguyen G, Szwarcer E, Conard J. Problems of t-plasminogen activator specific inhibitor determination in human plasma. Thromb Haemostasis. 1985; 54: 726–732
   Google Scholar
• Kruithof E KO, Vassalli J D., Schleuning W D., Mattaliano R J., Bachmann F. Purification and characterization of a plasminogen activator inhibitor from the histiocytic lymphoma cell line U-937. J Biol Chem. 1986; 261: 11207–11211
   PubMedGoogle Scholar
• Wan T C., Reich E. An inhibitor of plasminogen activation from human placenta. J Biol Chem. 1987; 262: 3646–3649
   Google Scholar
• Kopitar M, Rozman B, Babnik J, Turk V, Mullins D E., Wan T C. Human leukocyte urokinase inhibitor-purification, characterization and comparative studies against different plasminogen activators. Thromb Haemostasis. 1985; 54: 750–756
   Google Scholar
• Klimetsek V, Sorg C. The production of fibrinolysis inhibitors as a parameter of the activation state in murine macrophages. Eur J Immunol. 1979; 9: 613–619
   Google Scholar
• Erickson L A., Lawrence D A., Loskutoff D J. Reverse fibrin autograph: a method to detect and partially characterize protease inhibitors after sodium dodecylsulfate-polyacrylamide gel electrophoresis. Anal Biochem. 1984; 137: 454–462
   Google Scholar
• Kuroaka S, Campeau J D., Rodgers K E., Nakamura R M., Dizerega G S. Effects of interleukin 1 on postsurgical macrophage secretion of protease and protease inhibitor activities. J Surg Res. 1992; 52: 71–78
   Google Scholar